Antiarrhythmic Drugs: On completion of the course the learner will be able to:
-Know the Vaughn-Williams classification of the antiarrhythmic drugs.
-Be able to describe the effects of the antiarrhythmic drugs on the surface ECG.
-Be able to describe the pharmacokinetics of the antiarrhythmic drugs.
-Be able to describe the cardiac and non-cardiac side effects of the antiarrhythmic drugs.
-Be able to describe the relative therapeutic differences between amiodarone and dronedarone
Management of Supraventricular arrythmias: On completion of the course the learner will be able to:
-Be familiar with the management strategy for hemodynamically unstable bradycardia
-Be able to differentiate the pathophysiology and management of the two most common types of re-entry supraventricular tachycardias
-Understand the consequences of untreated atrial fibrillation
-Describe the management strategies for atrial fibrillation
-Be able to describe the use of anticoagulation in patients with atrial fibrillation
-Describe the use of drug therapy that can be used for pharmacologic conversion of atrial fibrillation
-Describe the use of drug therapy that can be used for ventricular rate control in atrial fibrillation
-Be able to describe the appropriate use of antithrombotic therapy in patients with atrial fibrillation
Management of Ventricular Arrythmias: On completion of this course the learner will be able to:
-Understand what defines ventricular ectopy
-Be familiar with the treatment algorithm for cardiac arrest
-Be familiar with the treatment algorithm for survivors of sudden cardiac death
-Be familiar with the indications for ICD therapy
-Be familiar with the treatment algorithm for monomorphic VT with a pulse
-Be familiar with the treatment algorithm for polymorphic (torsades des pointes) VT